Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INKASE: NK Cells and Inflammation in HIV
NCT05243381Unknown
- Sponsor
- CHU Montpellier
- Start
- Apr 2022
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by CHU Montpellier. Primary endpoint: Immune status of HIV-infected patients. Status: unknown.
Beyond the preview
Go deeper on NCT05243381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05243381.